From: Susceptible gene polymorphism in patients with three-vessel coronary artery disease
 | MACCE group (n = 342) | Non-CAD group (n = 344) | P-value |
---|---|---|---|
Age, year | 62.8 ± 10.2 | 50.5 ± 11.5 | < 0.0001 |
Male, % | 270 (78.9) | 198 (57.6) | < 0.0001 |
BMI, kg/m2 | 25.7 ± 3.2 | 25.3 ± 3.1 | 0.147 |
Hypertension, % | 241 (70.5) | 44 (12.8) | < 0.0001 |
DM, % | 134 (39.2) | 14 (4.1) | < 0.0001 |
Hyperlipidemia, % | 209 (61.1) | 25 (7.3) | < 0.0001 |
Stroke, % | 56 (16.4) | 1 (0.3) | < 0.0001 |
PVD, % | 31 (9.1) | 0 (0.0) | < 0.0001 |
Smoking history, % | 201 (58.8) | 64 (18.6) | < 0.0001 |
WBC, *109/L | 7.21 ± 2.08 | 6.25 ± 1.73 | < 0.0001 |
Hemoglobin, g/L | 136.7 ± 14.9 | 144.9 ± 12.3 | < 0.0001 |
ALT, IU/L | 30.2 ± 22.6 | 24.2 ± 16.0 | < 0.0001 |
Serum creatinine, μmol/L | 84.5 ± 22.0 | 72.6 ± 18.4 | < 0.0001 |
Uric acid, μmol/L | 322.1 ± 88.3 | 332.4 ± 98.2 | 0.151 |
Triglyceride, mmol/L | 1.77 ± 0.94 | 1.72 ± 1.19 | 0.533 |
Total cholesterol, mmol/L | 4.61 ± 1.07 | 4.68 ± 1.15 | 0.389 |
HDL-C, mmol/L | 1.05 ± 0.24 | 1.15 ± 0.32 | < 0.0001 |
LDL-C, mmol/L | 2.56 ± 0.81 | 2.87 ± 0.88 | < 0.0001 |
FPG, mmol/L | 6.31 ± 2.32 | 5.61 ± 1.23 | < 0.0001 |
CK-MB, IU/L | 19.4 ± 40.9 | 14.9 ± 4.5 | 0.046 |
Hs-CRP, mg/L | 3.77 ± 3.62 | 2.23 ± 1.57 | < 0.0001 |